Study of Autologous Skin Cell Treating for Diabetic Foot Ulcers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Diabetic foot ulcer is one of the refractory wounds and always poses many challenges in clinical practice. This study was conducted to have a prospective, randomised, controlled study compare the safety and efficacy of the autologous skin cell with skin graft (experiment group) with split-thickness skin graft (STSG, control group) alone on treating diabetic foot ulcers.
Epistemonikos ID: 141e1b95a549528ab4e7ed559bad1b96bda3f455
First added on: May 11, 2024